跳到正文
Oriol Mirallas MD· @DrMirallas · X·· 2026-04-19评分60
正文 · 原文

Minisymposium: Aiming for a Cure!

@AACR
#AACR26

Dr. Meric
@UTMDAnderson

NEOZanHER: PhII Zanidantamab for HER2+++ early (1-3cm, N0) #BC without any #chemotherapy

30% pCR
56% HER2 down regulation
All had a HER2 IHC3+, ERBB2 amplif
Much less toxicity

@OncoAlert

热度 9 · 5 赞 · 1 回复 · 3 转发

来源:Oriol Mirallas MD · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org